KR960010743B1 - Artificial implant and the method thereof - Google Patents

Artificial implant and the method thereof Download PDF

Info

Publication number
KR960010743B1
KR960010743B1 KR1019930024040A KR930024040A KR960010743B1 KR 960010743 B1 KR960010743 B1 KR 960010743B1 KR 1019930024040 A KR1019930024040 A KR 1019930024040A KR 930024040 A KR930024040 A KR 930024040A KR 960010743 B1 KR960010743 B1 KR 960010743B1
Authority
KR
South Korea
Prior art keywords
layer
calcium phosphate
implant
aluminum
phosphate compound
Prior art date
Application number
KR1019930024040A
Other languages
Korean (ko)
Other versions
KR950013482A (en
Inventor
김수룡
Original Assignee
쌍용양회공업주식회사
우덕창
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쌍용양회공업주식회사, 우덕창 filed Critical 쌍용양회공업주식회사
Priority to KR1019930024040A priority Critical patent/KR960010743B1/en
Publication of KR950013482A publication Critical patent/KR950013482A/en
Application granted granted Critical
Publication of KR960010743B1 publication Critical patent/KR960010743B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C4/00Coating by spraying the coating material in the molten state, e.g. by flame, plasma or electric discharge
    • C23C4/12Coating by spraying the coating material in the molten state, e.g. by flame, plasma or electric discharge characterised by the method of spraying
    • C23C4/134Plasma spraying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/12Materials or treatment for tissue regeneration for dental implants or prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction

Abstract

The structure of artificial tooth implant (I) consists of (1) a tooth body, (2) a linking layer, and (3) a contacting layer of 20-50% pore space. (2) is coated by spraying the hot melted mixture of alum and calcium phosphate 1:1.8-10.5 on (1). (3) is coated in 100-300 micron thickness by spraying the same mixture on (2) and treated by 0.1M sodium hydroxide or calcium hydroxide solution to solve alum to have 1-50 micron size of pores.

Description

복합 임플란트재 및 그의 제조방법Composite implant material and its manufacturing method

제1도는 본 발명의 의한 복합 임플란트의 단면도이다.1 is a cross-sectional view of a composite implant of the present invention.

*도면의 주요 부분에 대한 부호의 설명* Explanation of symbols for the main parts of the drawings

1 : 금속 임플란트 모재 2 : 제1층의 치밀층1: metal implant base material 2: dense layer of first layer

3 : 제2층의 다공정 표면층3: multi-process surface layer of 2nd layer

본 발명은 인공치근 및 인공관절 등에 이용되는 복합 임플란트재에 관한 것으로, 특히 강도와 인성이 뛰어나면서 생체친화성이 우수한 복합 임플란트재와 그의 제조방법이다.The present invention relates to a composite implant material used for artificial tooth roots, artificial joints, and the like, particularly a composite implant material having excellent strength and toughness and excellent biocompatibility, and a method of manufacturing the same.

일반적으로, 최근에 Co-Cr 합금, Ti 합금 또는 스텐레스강의 임플란트 재료가 다수의 의료분야에서 사용되고 있다. 그러나, 금속 임플란트재를 생체내에 이식후 장기간 체내에 넣어두면 체내의 조직액이나 체액에 의해 또는 체내에서 조직체와의 접촉 및 마찰로 인하여 급속 임프란트재의 급속이온이 용출되어 임플란트재를 부식시키게 된다. 또한, 금속 임플란트재로 부터 용출된 급속이온을 생체의 대식세포(macrophage)를 손상시키거나 생체내의 세포내에 침입하여 염증성세포 또는 거대세포를 발생시키는 원인이 된다.In general, implant materials of Co-Cr alloys, Ti alloys or stainless steels have recently been used in many medical applications. However, if the metal implant material is placed in the body for a long time after implantation in vivo, rapid ions of the rapid implant material are eluted by the tissue fluid or body fluid in the body or due to contact and friction with the tissue in the body to corrode the implant material. In addition, the rapid ions eluted from the metal implant material may damage macrophages of the living body or invade the cells of the living body to generate inflammatory cells or giant cells.

이와 같은 이유로 인하여 임플란트 모재의 표면에 생체친회성이 있는 수산화아파타이트 또는 인산3칼슘을 도포하거나(일본특허공개소 63-46165), 플라스마 아크를 이용하여 생체내에 안정한 물질로 코팅등의 표면처리(일본특허공개소 64-52471)를 하여 임플란트 모재를 구성하는 금속이온의 용출을 방지함과 동시에 생체친화성을 부여하는 방법이 제안되어 있다.For this reason, the surface of the implant base material is coated with biocompatible apatite hydroxide or tricalcium phosphate (Japanese Patent Publication No. 63-46165), or surface treatment such as coating with a stable material in vivo using plasma arc (Japan Patent Publication No. 64-52471) has been proposed to prevent the elution of the metal ions constituting the implant base material and to impart biocompatibility.

그러나, 이러한 방법들과 같이 금속모재에 피막을 형성하면 생성된 표면층이 비교적 치밀한 상태가되며, 표면층이 치밀해서 체내에 이식후 뼈세포가 임플란트재의 내부로 성장해 진입할 수 없는 현상이 발생한다. 따라서 임플란트와 생체경조직(뼈)과의 결합은 피막 표면에서 일어나는 화학적 결합력에만 의존하게 되므로서 임플란트재와 뼈와의 충분한 결합력이 확보되지 않는다는 단점이 남아 있었다.However, when the coating is formed on the metal base material as in these methods, the resulting surface layer becomes relatively dense, and the surface layer is dense so that bone cells cannot grow and enter into the implant material after implantation in the body. Therefore, the bond between the implant and the living hard tissue (bone) depends only on the chemical bonding force that occurs on the surface of the coating, there was a disadvantage that the sufficient bonding force between the implant material and the bone is not secured.

따라서, 본 발명의 목적은 이와 같은 종래의 임플란트재가 가지고 있는 생체경조직과의 결합력이 약한 문제점을 해결하기 위해서 복합 임플란트에 다공성을 형성시켜 뼈세포를 상기 복합 임플란트재의 가공 내부로 진입시켜 일정 기간 경과후 뼈로 성장할 수 있도록 하는데 있다.Accordingly, an object of the present invention is to form a porosity in the composite implant in order to solve the problem of weak bonding force with the living body tissue of such a conventional implant material to enter the bone cells into the processing of the composite implant material after a certain period of time To grow into bone.

즉, 임플란트재와 생체경조직(뼈) 사이에 화학결합과 더불어 기공 내부에 까지 자란 뼈와의 기계적결합을 동시에 추구하여 생체내에서 임플란트재의 조속한 정착과 안정을 제공하는데 그 목적이 있다.That is, the purpose is to provide rapid fixation and stabilization of the implant material in vivo by simultaneously pursuing a mechanical bond between the implant material and the biological hard tissue (bone) and bone grown up to the inside of the pores.

또한, 본원 발명은 고강도, 고인성을 가지며 특히, 생체친화성이 우수한 복합 임플란트를 제공하는데 그 목적이 있다.In addition, the present invention has a high strength, high toughness, and in particular, to provide a composite implant excellent in biocompatibility.

이하, 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.

본 발명은 금속 임플란트 모재(1)와 그 위에 제1층의 인산칼슘화합물의 치밀층(2)으로 된 복합 임플란트재에 있어서, 인산칼슘화합물로 된 제2층의 다공성 표면층(3)이 추가로 이루어지는 것을 특징으로 하는 복합 임플란트재이다.The present invention provides a composite implant material comprising a metal implant base material (1) and a dense layer (2) of calcium phosphate compound of the first layer thereon, wherein the porous surface layer (3) of the second layer of calcium phosphate compound is further added. It is a composite implant material characterized by the above-mentioned.

또한, 본 발명은 티타늄 또는 티타늄합금등으로 된 금속 임플란트 모재(1)에 플라스마 용사법에 의한 인산칼슘화합물로 제1층인 치밀층(2)을 형성시킨 복합 임플란트재의 제조방법에 있어서, 알루미늄 분말과 인산칼슘화합물 분말을 중량비로 1 : 1.8 내지 1 : 10.5의 범위로 혼합하여 상기 제1층의 치밀층(2)위에 플라스마 용사하고, 이어서 이것을 알칼리용액으로 처리하여 상기 알루미늄이 제거된 부위가 기공으로 생성되어 제2층의 다공성 표면층(3)이 추가로 형성되는 것을 특징으로 하는 복합 임플란트재의 제조방법인 것이다.In addition, the present invention is a method for producing a composite implant material in which a dense layer (2), which is the first layer, is formed of a calcium phosphate compound by a plasma spraying method on a metal implant base material (1) made of titanium or titanium alloy. The calcium compound powder is mixed in a weight ratio of 1: 1.8 to 1: 0.5, and plasma-sprayed on the dense layer 2 of the first layer, which is then treated with an alkaline solution to produce pores in which the aluminum is removed. It is a method for producing a composite implant material, characterized in that the porous surface layer 3 of the second layer is further formed.

이하, 본 발명을 더욱 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in more detail.

즉, 본 발명은 티타늄 또는 티타늄합금등의 금속 임플란트 모재(1)의 표면에 산화알루미늄 결정입자로 블라스팅 처리하여 요철면을 형성한다. 이렇게 형성된 금속 임플란트 모재(1)의 요철면은 금속 임플란트 모재(1)와 후술하는 인산칼슘화합물의 치밀층(2) 사이의 기계적 결합력을 증가시키게 된다.That is, the present invention forms an uneven surface by blasting with aluminum oxide crystal grains on the surface of the metal implant base material 1 such as titanium or titanium alloy. The uneven surface of the metal implant base material 1 thus formed increases the mechanical bonding force between the metal implant base material 1 and the dense layer 2 of the calcium phosphate compound described later.

이어서, 상기의 금속 임플란트 모재(1)에 칼슘 : 인의 몰비(Ca/P)가 약 1.5 및 1.67인 인산3칼숨 및 수산 화아파타이트 등의 인산화칼슘화합물 분말을 적어도 하나이상 플라스마 용사하여 30 내지 50㎛ 두께의 비교적 밀접한 제1층인 치밀층(2)을 형성시킴으로써 금속 임플란트 모재(1)를 체액 또는 체내조직체와 격리하여 금속 임플란트 모재(1)로부터 금속이온의 용출을 방지하게 된다.Subsequently, plasma spraying of at least one calcium phosphate compound powder such as tricalcium phosphate and apatite hydroxide having a calcium: phosphorus molar ratio (Ca / P) of about 1.5 and 1.67 to the metal implant base material 1 was carried out at 30 to 50 μm. By forming the dense layer 2, which is a relatively close first layer of thickness, the metal implant base material 1 is isolated from the body fluid or the body tissue to prevent elution of metal ions from the metal implant base material 1.

상기에서 플라스마 용사법이라 함은 고온의 플라스마 유체에 금속 또는 세라믹스 분말입자가 들어가 순간적으로 용융됨과 동시에 고속의 플라스마 유체에 실려 코팅을 목적으로 하는 모재에 강한 힘으로 충돌시키게 되며 플라스마 열로 인하여 용융된 입자는 금속 임플란트 모재에 충돌하면서 받는 충격에 의하여 납작하게 펴진 형태로 됨과 동시에 원래의 고체상태로 되돌아가 표면코딩 층을 형성하게 되는 코팅방법이다.In the above, plasma spraying means that metal or ceramic powder particles enter a high temperature plasma fluid and are melted instantaneously, and are loaded into a high-speed plasma fluid to collide with a strong force on a base material for coating purposes. It is a coating method to form a surface coating layer by returning to the original solid state and at the same time flattened by the impact received by the impact on the metal implant base material.

이어서, 제1층의 치밀층(2)위에 제2층의 다공성 표면층(3)을 형성하기 위하여 알루미늄 분말과 인산칼슘화합물 분말을 적정비율로 혼합하여 플라스마 용사법으로 코팅한다. 상기에서 알루미늄은 양쪽성 원소이므로 산이나 알칼리용액에 쉽게 용해되는 성질이 있는 반면에, 인산화칼슘화합물 분말을 산성 용액에서는 서서히 용해되지만, 알칼리용액에서 안정한 특성을 지니고 있다.Subsequently, in order to form the porous surface layer 3 of the second layer on the dense layer 2 of the first layer, aluminum powder and calcium phosphate compound powder are mixed at an appropriate ratio and coated by plasma spraying. Since aluminum is an amphoteric element, it has a property of being easily dissolved in an acid or an alkaline solution, whereas calcium phosphate compound powder is gradually dissolved in an acidic solution, but has stable properties in an alkaline solution.

따라서, 알루미늄 분말과 인산화칼슘화합물 분말을 적정비율로 혼합한 분말을 제1층의 치밀층(2)에 플라스마 코팅하게 되면 코팅층에는 알루미늄과 인산 칼슘화합물로 구성된 복합층이 존재하게 된다.Therefore, when plasma-coated powder in which aluminum powder and calcium phosphate compound powder are mixed at an appropriate ratio is plasma-coated on the dense layer 2 of the first layer, a composite layer composed of aluminum and calcium phosphate compound is present in the coating layer.

상기의 알루미늄 분말과 인산화칼슘 또는 수산화아파타이트등의 인산칼슘 화합물 분말을 중량비로 약 1 : 1.8 내지 약 1 : 10.5 범위로 하는 것이 적당하다.The above-mentioned aluminum powder and calcium phosphate compound powder such as calcium phosphate or apatite hydroxide are suitably in a weight ratio of about 1: 1.8 to about 1: 10.5.

이렇게 형성된 복합층을 약 0.1 몰농도의 수산화나트륨 또는 수산화 칼륨등의 알칼리성 용액에 침적시키면 인산칼슘화합물은 그대로 남아 있으나 알루미늄이 존재하던 부위는 선택적으로 알카리용액에 용해되게 된다. 따라서, 알루미늄이 용출되고 남은 인산칼슘 다공층은 3차원적으로 생체경조직 사이의 기계적 결합을 최적합하게는 20 내지 50%의 기공율을 작게 된다.When the composite layer thus formed is deposited in an alkaline solution such as sodium hydroxide or potassium hydroxide at about 0.1 molar concentration, the calcium phosphate compound remains as it is, but the portion where aluminum was present is selectively dissolved in the alkaline solution. Therefore, the calcium phosphate porous layer remaining after the aluminum is eluted has a small porosity of 20 to 50%, which is optimal for mechanical bonding between the living hard tissues in three dimensions.

생체경조직의 성장 및 임플란트재와 생체경조작 사이의 견고한 결합에 적합한 1 내지 50㎛범위 정도의 크기를 갖는 기공을 형성하기 위하여 상기 알루미늄과 인산칼슘화합물 분말의 입자크기는 약 100 내지 200㎛크기의 사용하여 두께 약 100 내지 300㎛범위의 코팅층을 형성하게 된다.The particle size of the aluminum and calcium phosphate compound powder is about 100 to 200 μm in order to form pores having a size in the range of 1 to 50 μm, which is suitable for growth of living tissue and firm bonding between the implant material and the bioscope. It is used to form a coating layer in the range of about 100 to 300㎛ thickness.

상기에서 형성되는 코팅층의 기공의 크기는 플라스마 용사법으로 코팅시 금속 임플란트 모재와의 충돌로 인하여 출발입자 보다 작아지기 때문에 목적하는 크기의 기공경 보다 통상 큰 입자를 사용하여야 한다.Since the size of the pores of the coating layer formed above is smaller than the starting particles due to the collision with the metal implant base material during the coating by the plasma spray method, particles larger than the pore diameter of the desired size should be used.

또한, 상기에서 제2층의 다공성 표면층(3)의 기공율이 20% 이하인 경우에는 임플란트재와 생체경조직내의 결합력이 충분하지 못하게 되고, 50% 이상인 경우에는 다공성 표면층(3) 자체의 기계적 강도가 취약하여 임플란트재와 생체경조직의 결합력의 상승효과가 얻어지지 않게 된다.In addition, when the porosity of the porous surface layer 3 of the second layer is 20% or less, the binding force between the implant material and the living body tissue is not sufficient, and when 50% or more, the mechanical strength of the porous surface layer 3 itself is weak. As a result, a synergistic effect of the bonding force between the implant material and the biological hard tissue is not obtained.

또한, 상기에서 제2층의 다공성 표면층(3)의 기공 크기가 1㎛이하이면 결합력이 충분하지 못하고, 기공의 크기가 50㎛이상이면 다공성 표면층(3)자체의 강도가 저하되어 적합하지 못하다.In addition, in the above, when the pore size of the porous surface layer 3 of the second layer is 1 μm or less, the bonding force is not sufficient, and when the pore size is 50 μm or more, the strength of the porous surface layer 3 itself is unsuitable.

더우기, 본 발명에서는 플라스마 코팅법을 이용하여 금속 임플란트 모재로 부터 표면층까지 다수의 층을 형성할 수 있고, 또한 각층의 필요한 성질에 알맞도록 층간의 기공경 및 기공율을 임의로 변경시킬 수 있다.In addition, in the present invention, the plasma coating method can be used to form a plurality of layers from the metal implant base material to the surface layer, and the pore size and porosity of the layers can be arbitrarily changed to suit the required properties of each layer.

또한, 상기의 알루미늄과 인산칼슘으로 구성된 코팅층을 알칼리용액에 일정시간 침적시키게 되면 알루미늄이 존재하는 부분만 선택적으로 반응이 일어나 용출되며, 알루미늄이 존재하던 곳이 3차원으로 연속된 기공으로 남게 되며 알칼리 용액으로는 수산화나트륨 또는 수산화칼륨 용액이 적합하며 알루미늄을 완전히 용출시키기 위하여 초음파 처리를 병행하면 더욱 효과적이다.In addition, when the coating layer composed of aluminum and calcium phosphate is deposited in an alkaline solution for a predetermined time, only a portion of aluminum is selectively reacted and eluted, and the place where aluminum is present remains as three-dimensional continuous pores. As a solution, sodium hydroxide or potassium hydroxide solution is suitable, and it is more effective to combine sonication to completely elute aluminum.

종래의 임플란트재는 콜라겐 섬유 및 뼈세포와 임플란트의 표면에서만 단순 결합을 유지하지만 본원 발명에 의한 경사기능 복합 임플란트재는 단순히 표면뿐만 아니라 형성된 기공내로도 콜라겐 섬유 및 뼈세포가 진입되게 되며 일정기간이 경과 후에는 뼈로 전환되어 인산칼슘과 직접 견고히 결합을 형성하게 된다.Conventional implant material maintains a simple bond only on the surface of the collagen fibers and bone cells and the implant, but the oblique functional implant material according to the present invention is to enter the collagen fibers and bone cells not only into the pores formed on the surface but also after a certain period of time Is converted to bone and forms a strong bond directly with calcium phosphate.

따라서, 생체경조직과 임플란트 사이에 표면을 비롯한 기공내부에서도 화학적, 기계적 결합이 이루어지기 때문에 임플란트 표면에서 화학적 결합에만 의지하던 종전의 임플란트재에 비하여 월등하게 강한 결합력을 함유하게 된다.Therefore, chemical and mechanical bonds are also formed in the pores, including the surface, between the living body tissue and the implant, so that the implant surface contains significantly stronger binding force than the conventional implant material, which relies only on chemical bonding.

즉, 본 발명에 의한 복합 임프란트재는 고강도 및 고인성의 금속 임플란트 모재(1)와 생체내에서 상기 금속 임플란트 모재(1)를 체액과 격리하여 금속 임플란트로 부터 금속이온이 용출되는 것을 방지하는 제1층의 치밀층(2)과 충분한 기공율과 기공경을 가지는 제2층의 다공성 표면층(3)으로 인하여 생체내에서 생체경조직의 성장을 유도하고, 생체경조직과 강력하게 결합하여 체내에서 안정성을 도모하는 효과를 지니게 된다.That is, the composite implant material according to the present invention is the first layer to isolate the metal implant base material (1) of high strength and high toughness and the metal implant base material (1) from the body fluid in vivo to prevent metal ions from eluting from the metal implant Due to the dense layer of (2) and the porous surface layer (3) of the second layer having sufficient porosity and pore diameter, it induces the growth of living body tissues in vivo, and strongly binds to the living body tissues to achieve stability in the body. Will have.

즉, 강인한 금속 임플란트 모재(1), 인산칼슘화합물의 치밀층(2), 그리고 인산칼슘화합물의 다공성 표면층(3)으로 구성된 복합 임플란트재는 각각의 특성을 발휘하면서 서로의 단점을 보완해주는 특성을 보유하게 된다.That is, the composite implant material composed of a strong metal implant base material (1), a dense layer of calcium phosphate compound (2), and a porous surface layer of calcium phosphate compound (3) exhibits properties that complement each other's shortcomings. Done.

이하, 본 발명을 실시예로 설명하면 다음과 같다.Hereinafter, the present invention will be described with reference to Examples.

실시예Example

티타늄으로 제조된 인공치근 또는 인공관절의 금속 임플란트 모재 표면을 약 50㎛의 산화알루미늄 입자로 블라스팅하여 표면에 요철을 형성시켜주면서 표면에 부착된 이물질 등을 깨끗이 제거하였다. 블라스팅 처리가 끝난 금속 임플란트 모재 표면에 칼슘 : 인의 몰비가(Cs/P)1.67인 수산화아파타티트 분말을 플라즈마 용사하여 50㎛두께의 치밀층을 형성하였다. 이어서, 다공성 표면층을 제조하기 위하여 100∼200㎛크기의 알루미늄 분말과 수산화아파타이트 분말을 중량비고 1 : 4.7이 되도록 혼합분말을 준비하고 플라스마 코팅하여 약 200㎛두께의 표면층을 형성하였다. 플라즈마 용사처리가 끝난 임플란트를 0.1몰 농도의 수산화나트륨 용액에 넣고 약3분간 초음파 처리하였다.The surface of the metal implant base material of the artificial tooth root or artificial joint made of titanium was blasted with aluminum oxide particles having a thickness of about 50 μm to form irregularities on the surface, thereby removing foreign substances attached to the surface. On the surface of the blast-treated metal implant base material, a hydroxide sprayed apatite powder having a calcium: phosphorus molar ratio (Cs / P) of 1.67 was plasma sprayed to form a dense layer having a thickness of 50 μm. Subsequently, in order to prepare a porous surface layer, a mixed powder was prepared such that the aluminum powder having a size of 100 to 200 μm and the apatite hydroxide powder were 1: 1: 4.7 by weight, and then plasma coated to form a surface layer having a thickness of about 200 μm. The plasma sprayed implant was placed in a 0.1 mol sodium hydroxide solution and sonicated for about 3 minutes.

알루미늄이 제거된 임플란트를 흐르는 증류수에서 세척후 기공내부에 존재할 수 있는 수산화나트륨용액을 제거하기 위하여 증류수가 담긴 초음파 세척기에 넣고 약 5분간 충분히 세척하였다. 다공성 표면층의 기공 내부의 수산화나트륨을 완전히 제거한 후, 복합 임플란트재를 100±5℃건조기에 넣고 24시간 건조하여 기공율 30%, 평균기공경 20㎛의 다공성 표면층을 가진 복합 임플란트재를 제조하였다.The aluminum-free implant was washed in flowing distilled water and then placed in an ultrasonic cleaner containing distilled water to remove sodium hydroxide solution that may be present in the pores. After completely removing the sodium hydroxide inside the pores of the porous surface layer, the composite implant material was put in a 100 ± 5 ℃ dryer for 24 hours to prepare a composite implant material having a porous surface layer of 30% porosity, the average pore diameter of 20㎛.

Claims (5)

금속 임플란트 모재(1)와 그 위에 인산칼슘화합물의 치밀층(2)으로 된 복합 임플란트재에 있어서, 이위에 인산칼슘화합물로 된 다공성 표면층(3)이 추가로 이루어지는 것을 특징으로 하는 복합 임플란트재.A composite implant material comprising a metal implant base material (1) and a dense layer (2) of calcium phosphate compound thereon, the composite implant material further comprising a porous surface layer (3) of calcium phosphate compound thereon. 제1항에 있어서, 다공성 표면층(3)은 기공율 20 내지 50%, 기공경 1 내지 50㎛, 두께 100 내지 300㎛인 것을 특징으로 하는 복합 임플란트재.The composite implant material according to claim 1, wherein the porous surface layer (3) has a porosity of 20 to 50%, a pore diameter of 1 to 50 mu m, and a thickness of 100 to 300 mu m. 금속 임플란트 모재(1)에 플라즈마 용사법에 의해 고순도 인산칼슘화합물로 제1층인 치밀층(2)의 복합 임플란트재를 제조하는 방법에 있어서, 알루미늄 분말과 인산칼슘화합물 분말을 중량비로 1 : 1.8 내지 1 : 10.5의 범위로 혼합하여 상기 제1층의 치밀층(2)위에 플라스마 용사하고, 이어서 이것을 알칼리용액으로 처리하여 상기 알루미늄이 제거된 부위가 기공으로 생성되어 제2층의 다공성 표면층(3)이 형성되는 것을 특징으로 하는 복합 임플란트의 제조방법.A method for producing a composite implant material of a dense layer (2), which is the first layer, of a high purity calcium phosphate compound on a metal implant base material (1) by plasma spraying, comprising aluminum powder and calcium phosphate compound powder in a weight ratio of 1: 1.8 to 1 : By mixing in the range of 10.5 and plasma-sprayed on the dense layer 2 of the first layer, and then treated with an alkaline solution to form the pores where the aluminum is removed, thereby forming the porous surface layer 3 of the second layer. Method for producing a composite implant, characterized in that formed. 제3항에 있어서, 제2층의 다공성 표면층(3)에 플라스마 용사되는 알루미늄 및 인산칼슘화합물 분말의 입자크기는 100 내지 200㎛ 범위로 하는 것을 특징으로 하는 복합 임플란트의 제조방법.4. The method of claim 3, wherein the particle size of the aluminum and calcium phosphate powder plasma sprayed on the porous surface layer (3) of the second layer is in the range of 100 to 200 mu m. 제3항에 있어서, 알칼리 용액은 0.1몰 농도의 수산화나트륨 또는 수산화칼륨 용액인 것을 특징으로 하는 복합 임플란트의 제조방법.4. The method of claim 3, wherein the alkaline solution is 0.1 molar sodium hydroxide or potassium hydroxide solution.
KR1019930024040A 1993-11-12 1993-11-12 Artificial implant and the method thereof KR960010743B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930024040A KR960010743B1 (en) 1993-11-12 1993-11-12 Artificial implant and the method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930024040A KR960010743B1 (en) 1993-11-12 1993-11-12 Artificial implant and the method thereof

Publications (2)

Publication Number Publication Date
KR950013482A KR950013482A (en) 1995-06-15
KR960010743B1 true KR960010743B1 (en) 1996-08-08

Family

ID=19367920

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930024040A KR960010743B1 (en) 1993-11-12 1993-11-12 Artificial implant and the method thereof

Country Status (1)

Country Link
KR (1) KR960010743B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100655170B1 (en) * 2005-04-07 2006-12-08 한국과학기술원 Artificial joint system
KR100611945B1 (en) * 2005-10-04 2006-08-11 주식회사 메가젠 Implant surface treatment method using electrolyte solution and implant manufactured by the same

Also Published As

Publication number Publication date
KR950013482A (en) 1995-06-15

Similar Documents

Publication Publication Date Title
Jemat et al. Surface modifications and their effects on titanium dental implants
Liu et al. Bioactive calcium phosphate coating formed on micro-arc oxidized magnesium by chemical deposition
JP2858126B2 (en) Biological implant material and its manufacturing method
Lacefield Materials characteristics of uncoated/ceramic-coated implant materials
US7132015B2 (en) Materials for dental and biomedical application
US9421151B2 (en) Coating method
JP2001269357A (en) Living body implant material, and method of manufacturing for the same
AU2003224334A1 (en) A dental or orthopaedic implant
Oguchi et al. Evaluation of a high-velocity flame-spraying technique for hydroxyapatite
US4794023A (en) Process for producing a calcium phosphate compound coated composite material
JP3461818B2 (en) Hard tissue repair material and method for producing the same
RU2146535C1 (en) Method for manufacturing of intrabone dental implant with multilayer biologically active plasma deposit
KR960010743B1 (en) Artificial implant and the method thereof
Oktar et al. Bond-coating in plasma-sprayed calcium-phosphate coatings
JP2883214B2 (en) Biological implant material and its manufacturing method
KR101203814B1 (en) Etching and Biocompatible Thin Film Coated Methods for Surface of Implant
Park et al. Bioactive Calcium Phosphate Coating on Sodium Hydroxide‐Pretreated Titanium Substrate by Electrodeposition
Jubhari et al. Implant coating materials to increase osseointegration of dental implant: A systematic review
JP3455382B2 (en) Implant material
Frayssinet et al. A study of structure and degradation of nonpolymeric biomaterials implanted in bone using reflected and transmitted light microscopy
JP4282799B2 (en) Process for producing β-tricalcium phosphate coating
AU2020102595A4 (en) Novel osteoconductive material composition and coating thereof.
JPH05146504A (en) Organism implantation member and manufacture thereof
JPH0747116A (en) Manufacture of implant
JPH0139787B2 (en)

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20000711

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee